Latest News and Press Releases
Want to stay updated on the latest news?
-
Dublin, May 15, 2025 (GLOBE NEWSWIRE) -- The "Lucentis (Ranibizumab) Market Report 2025: Epidemiology, Pipeline Analysis, Market Insights & Forecasts" report has been added to ...
-
Dublin, Nov. 22, 2024 (GLOBE NEWSWIRE) -- The "Wet Age-Related Macular Degeneration (Wet AMD) - Pipeline Insight, 2024" report has been added to ResearchAndMarkets.com's offering. The emergent...
-
Dublin, Nov. 08, 2024 (GLOBE NEWSWIRE) -- The "Age-Related Macular Degeneration (AMD) Drugs Market by Product (Lucentis, Eylea & Eylea HD, Vabysmo, Syfovre), Molecule (Ranibizumab, Aflibercept,...
-
Dublin, Oct. 24, 2024 (GLOBE NEWSWIRE) -- The "Ranibizumab (Lucentis) Biosimilars Pipeline Review" report has been added to ResearchAndMarkets.com's offering.This product provides basic information...
-
NEWARK, Del, March 21, 2023 (GLOBE NEWSWIRE) -- The global retinal vein occlusion treatment market is likely to register a CAGR of 5.9% from 2023 to 2033. According to Future Market Insights, a...
-
Dublin, Jan. 10, 2023 (GLOBE NEWSWIRE) -- The "Diabetic Macular Edema Treatment Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies...
-
Dublin, April 07, 2021 (GLOBE NEWSWIRE) -- The "Vascular Endothelial Growth Factor (VEGF) Inhibitor Global Market Opportunities and Strategies to 2030: COVID-19 Impact and Recovery" report has been...
-
Dublin, Dec. 21, 2020 (GLOBE NEWSWIRE) -- The "Diabetic Retinopathy - Global Drug Forecast and Market Analysis to 2029" report has been added to ResearchAndMarkets.com's offering. Currently, only...
-
Dublin, Dec. 17, 2020 (GLOBE NEWSWIRE) -- The "Retinal Vein Occlusion - Market Insights, Epidemiology, and Market Forecast - 2030" drug pipelines has been added to ResearchAndMarkets.com's offering....